[Clinical characteristics and treatment of desmoplastic small round cell tumor]

Zhonghua Zhong Liu Za Zhi. 2010 Feb;32(2):139-42.
[Article in Chinese]

Abstract

Objective: To investigate the clinical characteristics and treatment of desmoplastic small round cell tumor.

Methods: Five patients with DSRCT were diagnosed and treated in our Hospital from January 1999 to May 2009. Forty-eight cases with complete clinical data were collected and reviewed from 23 published reports. Therefore totally 53 patients with DSRCT were analysed. The survival rate was calculated by Kaplan-Meier method and compared by log-rank test.

Results: The median age of all cases was 23 (1.5 - 66) years old at the time of diagnosis. 75.5% of patients were male. The most common presenting complaint was intra-abdominal mass or pain (77.4%). In 46 patients (86.8%), the primary tumor was located in the abdomen or pelvis. Fifteen (28.3%) had positive lymph nodes or distant parenchymal metastases. The median follow-up was 1.8 years (range, 0.1 - 10.0 years). The overall 1-, 3- and 5-year survivals were 45.8%, 20.8% and 5.7%, respectively. Forty-seven patients underwent surgery. Complete tumor resection was significantly correlated with long survival. The 1- and 3-year survival rates were 70.5% and 53.7% in patients treated with complete tumor resection compared to 37.2% and 4.8% in the incomplete tumor resection cohort (P = 0.0020). Thirty-four patients received chemotherapy and the 1- and 3-year survival rates were 60.1% and 35.2%, respectively, however, only 29.7% and 12.7% in patients without chemotherapy (P = 0.0396). Twelve patients had radiotherapy and the 1- and 3-year survival rates were 75.0% and 38.9%, respectively, compared with 36.9% and 14.8% in those without radiotherapy (P = 0.0314).

Conclusion: Complete tumor resection results in improved survival in patients with DSRCT. Chemotherapy and radiotherapy correlate with improved patient outcome. Multimodal therapy may improve the survival in patients with DSRCT.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Abdominal Neoplasms / pathology*
  • Abdominal Neoplasms / therapy*
  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Neoplasms / secondary
  • Combined Modality Therapy
  • Cyclophosphamide / therapeutic use
  • Desmoplastic Small Round Cell Tumor / pathology*
  • Desmoplastic Small Round Cell Tumor / secondary
  • Desmoplastic Small Round Cell Tumor / therapy*
  • Doxorubicin / therapeutic use
  • Etoposide / therapeutic use
  • Female
  • Follow-Up Studies
  • Humans
  • Ifosfamide / therapeutic use
  • Liver Neoplasms / secondary
  • Lymph Node Excision
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / therapy
  • Radiotherapy, Conformal
  • Surgical Procedures, Operative
  • Survival Rate
  • Vincristine / therapeutic use
  • Young Adult

Substances

  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Ifosfamide

Supplementary concepts

  • IVAD protocol